2023. Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), 686–695. DOI:https://doi.org/10.25251/skin.7.2.5.